Anxiety Disorders Therapeutic Pipeline Market Review H2 2014 Report at RnRMarketReserach.com
Dallas, TX (PRWEB) December 08, 2014 -- The report "Anxiety Disorders Pipeline Review H2 2014" is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. This report provides comprehensive information on the therapeutic development for Anxiety Disorders, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anxiety Disorders and special features on late-stage and discontinued projects. Complete Report is Available @ http://www.rnrmarketresearch.com/anxiety-disorders-pipeline-review-h2-2014-market-report.html .
Companies discussed in this Anxiety Disorders Pipeline Review H2 2014 report include:
• Ache Laboratorios Farmaceuticos S/A
• Adamed Sp. z o.o.
• Addex Therapeutics Ltd
• Avineuro Pharmaceuticals, Inc.
• Azevan Pharmaceuticals, Inc.
• Beech Tree Labs, Inc.
• Bionomics Limited
• Boehringer Ingelheim GmbH
• C4X Discovery Ltd
• Concert Pharmaceuticals, Inc.
• Eisai Co., Ltd.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• GW Pharmaceuticals plc
• HolsboerMaschmeyer NeuroChemie GmbH
• Johnson & Johnson
• Merz Pharmaceuticals GmbH
• MI.TO. Technology S.r.L.
• Newron Pharmaceuticals S.p.A.
• Nuvo Research Inc.
• Omeros Corporation
• Richter Gedeon Nyrt.
• Rottapharm SpA
• Sigma-Tau S.p.A.
• SK Biopharmaceuticals Co., Ltd.
• Suda Ltd
• Sumitomo Dainippon Pharma Co., Ltd.
• Trevena, Inc.
Drugs profile discussed in this Anxiety Disorders Pipeline Review H2 2014 report include ADN-2013, ADX-71441, ADX-88178, alprazolam, AVL-5189, AVN-101, AVN-397, AVN-628, AZ-01, BCA-909, BNC-210, BTL-ng, CR-5542 Series, CTP-354 and dipraglurant IR. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=248264 .
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Major points in Table of Content
List of Tables
Number of Products under Development for Anxiety Disorders, H2 2014
Number of Products under Development for Anxiety Disorders - Comparative Analysis, H2 2014
Number of Products under Development by Companies, H2 2014
Number of Products under Development by Companies, H2 2014 (Contd..1)
Number of Products under Development by Companies, H2 2014 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H2 2014
Comparative Analysis by Clinical Stage Development, H2 2014
Comparative Analysis by Early Stage Development, H2 2014
Comparative Analysis by Unknown Stage Development, H2 2014
Products under Development by Companies, H2 2014
Products under Development by Companies, H2 2014 (Contd..1)
Products under Development by Companies, H2 2014 (Contd..2)
Products under Investigation by Universities/Institutes, H2 2014
Anxiety Disorders - Pipeline by Ache Laboratorios Farmaceuticos S/A, H2 2014
Anxiety Disorders - Pipeline by Adamed Sp. z o.o., H2 2014
Anxiety Disorders - Pipeline by Addex Therapeutics Ltd, H2 2014
Anxiety Disorders - Pipeline by Avineuro Pharmaceuticals, Inc., H2 2014
Anxiety Disorders - Pipeline by Azevan Pharmaceuticals, Inc., H2 2014
Anxiety Disorders - Pipeline by Beech Tree Labs, Inc., H2 2014
Anxiety Disorders - Pipeline by Bionomics Limited, H2 2014
Anxiety Disorders - Pipeline by Boehringer Ingelheim GmbH, H2 2014
Anxiety Disorders - Pipeline by C4X Discovery Ltd, H2 2014
Anxiety Disorders - Pipeline by Concert Pharmaceuticals, Inc., H2 2014
Anxiety Disorders - Pipeline by Eisai Co., Ltd., H2 2014
Anxiety Disorders - Pipeline by Eli Lilly and Company, H2 2014
Anxiety Disorders - Pipeline by F. Hoffmann-La Roche Ltd., H2 2014
Anxiety Disorders - Pipeline by GW Pharmaceuticals plc, H2 2014
Anxiety Disorders - Pipeline by HolsboerMaschmeyer NeuroChemie GmbH, H2 2014
Anxiety Disorders - Pipeline by Johnson & Johnson, H2 2014
Anxiety Disorders - Pipeline by Merz Pharmaceuticals GmbH, H2 2014
Anxiety Disorders - Pipeline by MI.TO. Technology S.r.L., H2 2014
Anxiety Disorders - Pipeline by Newron Pharmaceuticals S.p.A., H2 2014
Anxiety Disorders - Pipeline by Nuvo Research Inc., H2 2014
Anxiety Disorders - Pipeline by Omeros Corporation, H2 2014
Anxiety Disorders - Pipeline by Richter Gedeon Nyrt., H2 2014
Anxiety Disorders - Pipeline by Rottapharm SpA, H2 2014
Anxiety Disorders - Pipeline by Sigma-Tau S.p.A., H2 2014
Anxiety Disorders - Pipeline by SK Biopharmaceuticals Co., Ltd., H2 2014
Anxiety Disorders - Pipeline by Suda Ltd, H2 2014
Anxiety Disorders - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H2 2014
Anxiety Disorders - Pipeline by Trevena, Inc., H2 2014
Explore more reports on Mental Illness Drugs industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment/mental-illness-drugs .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, RnR Market research, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]
Share this article